First Diagnostic Test for Long Covid, Detecting Spike Protein in Blood, to Launch in September. Or is it ‘Long Vaccine’?

Authors{ WILL JONES 3 SEPTEMBER 2022  The first diagnostic designed to identify patients with Long Covid has received CE-IVD marking in Europe, meaning it is ready for its formal launch…[...]

Read More

Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19

Authors : Mirren Charnley, Saba Islam,  Guneet K. Bindra,  Jeremy Engwirda,  Julian Ratcliffe,  Jiangtao Zhou,  Raffaele Mezzenga,  Mark D. Hulett,  Kyunghoon Han,  Joshua T. Berryman & Nicholas P. Reynolds  Nature Communications volume 13, Article number: 3387 (2022)  July…[...]

Read More

The Impact of Initial COVID-19 Episode Inflammation Among Adults on Mortality Within 12 Months Post-hospital Discharge

Authors: Arch G. Mainous III1,2*, Benjamin J. Rooks1 and Frank A. Orlando1 May 12, 2022 Frontiers in Medicine Background: Inflammation in the initial COVID-19 episode may be associated with post-recovery mortality. The goal of…[...]

Read More

Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador

Authors: Ariel Torres, Martha Fors, Tamaris Rivero, Karina Pantoja & Santiago Ballaz  BMC Infectious Diseases volume 21, Article number: 558 (2021)  Abstract Background The quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) effectively detects the SARS-COV-2 virus. SARS-CoV-2 Nevertheless, some critical gaps…[...]

Read More